IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $2.14M invested in Interpace Biosciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$880K |
2 |
MFG
Magnus Financial Group
New York
|
+$150K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$107K |
4 |
Squarepoint
New York
|
+$78K |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$40K |
Top Sellers
1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$190K |
2 |
VF
Virtu Financial
New York
|
-$55K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |